ACADIA Pharmaceuticals
ACAD
#3900
Rank
€2.28 B
Marketcap
13,79 €
Share price
-0.62%
Change (1 day)
-31.99%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): -0,86 €

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,83 €. In 2022 the company made an earnings per share (EPS) of -1,21 € a decrease over its 2021 EPS that were of -0,95 €.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,86 €-28.91%
2022-1,21 €27.62%
2021-0,95 €-41.67%
2020-1,62 €12.5%
2019-1,44 €-17.95%
2018-1,76 €-17.02%
2017-2,12 €0.43%
2016-2,11 €43.56%
2015-1,47 €73.4%
2014-0,85 €113.64%
2013-0,40 €18.92%
2012-0,33 €-15.91%
2011-0,40 €-210%
20100,36 €-133.61%
2009-1,07 €-30.81%
2008-1,55 €7.5%
2007-1,44 €-0.62%
2006-1,45 €4.55%
2005-1,39 €-14.61%
2004-1,63 €-84.26%
2003-10,34 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
0,24 €-129.35%🇺🇸 USA
1,68 €-302.17%🇺🇸 USA
4,90 €-690.14%🇺🇸 USA
12,71 €-1,631.01%🇺🇸 USA
3,58 €-531.52%🇺🇸 USA